glimepiride 4mg tablets
a a h pharmaceuticals ltd - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
niche generics ltd - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
zentiva pharma uk ltd - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
waymade healthcare plc - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
dr reddy's laboratories (uk) ltd - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
kent pharma (uk) ltd - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
sun pharma uk ltd - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
consilient health ltd - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
sigma pharmaceuticals plc - glimepiride - oral tablet - 4mg
glimepiride tablet
dr. reddy's laboratories limited - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 1 mg - glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies (14.1) ]. limitations of use glimepiride tablets should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets are contraindicated in patients with a history of a hypersensitivity reaction to: - glimepiride or any of the product’s ingredients [see warnings and precautions (5.2) ]. - sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives. risk summary available data from a small number of published studies and postmarketing experience with glimepiride use in pregnancy over decades have not identified any drug associated risks for major birth defects, miscarria